Dopaminergic Agonists in Parkinson’s Disease
Author:
- 1 January 2010
- book chapter
- Published by Elsevier
- p. 332-337
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Dopamine agonists in Parkinson’s diseaseExpert Review of Neurotherapeutics, 2008
- Apomorphine therapy in Parkinson's disease: a reviewExpert Opinion on Pharmacotherapy, 2007
- Advanced Parkinson disease treated with rotigotine transdermal systemNeurology, 2007
- Slower progression of Parkinson's disease with ropinirole versus levodopa: The REAL‐PET studyAnnals of Neurology, 2003
- Induction by Dopamine D1 Receptor Agonist ABT-431 of Dyskinesia Similar to Levodopa in Patients With Parkinson DiseaseArchives of Neurology, 2001
- Pramipexole vs Levodopa as Initial Treatment for Parkinson DiseaseJAMA, 2000
- A Five-Year Study of the Incidence of Dyskinesia in Patients with Early Parkinson's Disease Who Were Treated with Ropinirole or LevodopaNew England Journal of Medicine, 2000
- Double-blind comparison of pramipexole and bromocriptine treatment with placebo in advanced Parkinson's diseaseNeurology, 1997
- Efficacy of pramipexole, a novel dopamine agonist, as monotherapy in mild to moderate Parkinson's diseaseNeurology, 1997
- Bromocriptine in ParkinsonismBMJ, 1974